| Update in pulmonary carcinoid tumors: a review article R Hage, AB de la Rivière, CA Seldenrijk, JMM Van den Bosch Annals of Surgical Oncology 10, 697-704, 2003 | 280 | 2003 |
| Surgery for combined type small cell lung carcinoma R Hage, JRJ Elbers, AB de la Rivière, JMM Van den Bosch Thorax 53 (6), 450-453, 1998 | 69 | 1998 |
| Pulmonary large-cell neuroendocrine carcinoma (LCNEC) R Hage, K Seldenrijk, P de Bruin, H van Swieten, J van den Bosch European journal of cardio-thoracic surgery 23 (4), 457-460, 2003 | 58 | 2003 |
| Combined pulmonary fibrosis and emphysema (CPFE) clinical features and management R Hage, F Gautschi, C Steinack, MM Schuurmans International Journal of Chronic Obstructive Pulmonary Disease, 167-177, 2021 | 43 | 2021 |
| Neural cell adhesion molecule expression: prognosis in 889 patients with resected non-small cell lung cancer R Hage, HRJ Elbers, AB De La Rivière, JMM Van Den Bosch Chest 114 (5), 1316-1320, 1998 | 43 | 1998 |
| COVID-19 in patients with solid organ transplantation: a systematic review R Hage, C Steinack, C Benden, MM Schuurmans Transplantology 1 (1), 1-15, 2020 | 30 | 2020 |
| Calcineurin inhibitors revisited: A new paradigm for COVID-19? R Hage, C Steinack, MM Schuurmans Brazilian Journal of Infectious Diseases 24, 365-367, 2020 | 25 | 2020 |
| Improved glucose tolerance after initiation of Elexacaftor/Tezacaftor/Ivacaftor in adults with cystic fibrosis C Steinack, M Ernst, F Beuschlein, R Hage, M Roeder, MM Schuurmans, ... Journal of Cystic Fibrosis 22 (4), 722-729, 2023 | 22 | 2023 |
| Electronic cigarettes and vaping associated pulmonary illness (VAPI): A narrative review R Hage, V Fretz, MM Schuurmans Pulmonology 26 (5), 291-303, 2020 | 22 | 2020 |
| COVID-19-related end stage lung disease: two distinct phenotypes K Kostopanagiotou, MM Schuurmans, I Inci, R Hage Annals of Medicine 54 (1), 588-590, 2022 | 19 | 2022 |
| Suggested management of e-cigarette or vaping product use associated lung injury (EVALI) R Hage, MM Schuurmans Journal of Thoracic Disease 12 (7), 3460, 2020 | 17 | 2020 |
| Transbronchial cryobiopsy compared to forceps biopsy for diagnosis of acute cellular rejection in lung transplants: analysis of 63 consecutive procedures C Steinack, A Gaspert, F Gautschi, R Hage, B Vrugt, A Soltermann, ... Life 12 (6), 898, 2022 | 14 | 2022 |
| Primitive neuroectodermal tumor: report of two cases and review of the literature R Hage, VAM Duurkens, CA Seldenrijk, AB de la Rivière, HA van Swieten, ... The Journal of Thoracic and Cardiovascular Surgery 124 (4), 833-836, 2002 | 13 | 2002 |
| Transplant drugs against SARS, MERS and COVID-19 R Hage, C Steinack, F Gautschi, MM Schuurmans Transplantology 1 (2), 71-84, 2020 | 6 | 2020 |
| Clinical characteristics, treatments and outcomes of 18 lung transplant recipients with COVID-19 R Hage, C Steinack, F Gautschi, S Pfister, I Inci, MM Schuurmans Transplantology 2 (2), 229-245, 2021 | 5 | 2021 |
| Cyclosporine A and COVID-19–The COQUIMA cohort MM Schuurmans, R Hage EClinicalMedicine 31, 2021 | 5 | 2021 |
| SARS-CoV-2 and norovirus co-infection after lung transplantation C Steinack, R Hage, C Benden, MM Schuurmans Transplantology 1 (1), 16-23, 2020 | 4 | 2020 |
| Multimodal Remote Home Monitoring of Lung Transplant Recipients during COVID-19 Vaccinations: Usability Pilot Study of the COVIDA Desk Incorporating Wearable Devices MM Schuurmans, M Muszynski, X Li, R Marcinkevičs, L Zimmerli, ... Medicina 59 (3), 617, 2023 | 2 | 2023 |
| Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol MM Schuurmans, ME Raeber, M Roeder, R Hage Medicina 59 (3), 488, 2023 | 2 | 2023 |
| Calcineurin Inhibitors and COVID-19 R Hage, MM Schuurmans Reumatologia clinica 18 (5), 314, 2022 | 2 | 2022 |
